CIK 0001823239 · Accelerated filer
MARAVAI LIFESCIENCES HOLDINGS, INC.
Sign in to watch- Ticker
- MRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858) 546-0004
- Business address
- 10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-08 | GTCR INVESTMENT XI LLC Director | Returned to the company · Common Units | −2,304,256 | $31.25 | $72.0M | 143,308,170 |
| 2021-04-07 | GTCR INVESTMENT XI LLC Director | Returned to the company | −2,638,297 | $31.25 | $82.4M | 25,008,218 |
| 2021-04-07 | GTCR INVESTMENT XI LLC Director | Other disposition | −15,361,703 | 145,612,426 | ||
| 2021-04-07 | GTCR INVESTMENT XI LLC Director | Returned to the company · Common Units | −15,361,703 | $31.25 | $480.1M | 145,612,426 |
| 2020-11-25 | HULL CARL Chief Executive Officer | Purchase | +35,000 | $26.94 | $943K | 35,000 |
| 2020-11-24 | GTCR INVESTMENT XI LLC Director | Returned to the company | −1,319,148 | $25.52 | $33.7M | 27,646,515 |
| 2020-11-24 | GTCR INVESTMENT XI LLC Director | Other disposition | −7,680,852 | 160,974,129 | ||
| 2020-11-24 | GTCR INVESTMENT XI LLC Director | Returned to the company · Common Units | −55,823,011 | $25.52 | $1.4B | 160,974,129 |
| 2020-11-24 | GRAY SUSANNAH Director | Purchase | +20,000 | $27.00 | $540K | 31,852 |
| 2020-11-24 | SELLERS LISA See Remarks | Purchase | +18,888 | $27.00 | $510K | 18,888 |
| 2020-11-24 | Hance Robert B Director | Purchase | +10,000 | $27.00 | $270K | 21,852 |
| 2020-11-24 | PRAHALAD MURALI Director | Purchase | +18,000 | $27.00 | $486K | 29,852 |
| 2020-11-24 | LUCIER GREGORY T Director | Purchase | +15,000 | $27.00 | $405K | 26,852 |
| 2020-11-24 | Hopfield Jessica Director | Purchase | +50,000 | $27.00 | $1.4M | 61,852 |
| 2020-11-24 | ORESHACK KURT General Counsel | Purchase | +7,500 | $27.00 | $203K | 7,500 |
| 2020-11-19 | Dolan Christine See Remarks | Grant or award · Employee Stock Options (Right to Buy) | +60,000 | 60,000 | ||
| 2020-11-19 | NEEL BRIAN See Remarks | Grant or award · Employee Stock Options (Right to Buy) | +60,000 | 60,000 | ||
| 2020-11-19 | LUCIER GREGORY T Director | Grant or award | +11,852 | 11,852 | ||
| 2020-11-19 | ORESHACK KURT General Counsel | Grant or award · Employee Stock Options (Right to Buy) | +40,000 | 40,000 | ||
| 2020-11-19 | HULL CARL Chief Executive Officer | Grant or award · Employee Stock Options (Right to Buy) | +60,000 | 60,000 |
Page 12 of 13 · 248 trades